AlbertoJoseMonteroMDMBA, CPHQ

PubMed

• Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
  Miguel Martín, Elgene Lim, Mariana Chavez-MacGregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian...> ;Journal of Clinical Oncology. 2024 Mar 27
• Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.
  Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, Carley Mitchell, Paul G Pavicic Jr, Pingfu Fu, Amit Rupani, Hana Husic, Patricia A Rayman, Shad...> ;Clinical Cancer Research. 2024 Jan 5
• Management of Neuroendocrine Breast Carcinoma (NEBC): Review of Literature.
  Mohamed, A., Zeidalkilani, J., Asa, S., Trybula, M., Montero, A.> ;Oncology Reviews. 2024 Jan 1
• Estimating the overall survival benefit of adjuvant chemo-endocrine therapy in women over age 50 with pT1-2N0 early stage breast cancer and 21-gene recurrence score ≥2...
  Nickolas Stabellini, Lifen Cao, Christopher W Towe, Amanda L Amin, Alberto J Montero> ;Cancer Medicine. 2023 Oct 1
• 1 citations
  Social Determinants of Health Data Improve the Prediction of Cardiac Outcomes in Females with Breast Cancer.
  Nickolas Stabellini, Jennifer Cullen, Justin X Moore, Susan Dent, Arnethea L Sutton, John Shanahan, Alberto J Montero, Avirup Guha> ;Cancers. 2023 Sep 19
• Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer.
  Mohammadhadi Khorrami, Vidya Sakar Viswanathan, Priyanka Reddy, Nathaniel Braman, Siddharth Kunte, Amit Gupta, Jame Abraham, Alberto J Montero, Anant Madabhushi> ;NPJ Breast Cancer. 2023 Aug 11
• 2 citations
  Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer.
  Nickolas Stabellini, Mantas Dmukauskas, Marcio S Bittencourt, Jennifer Cullen, Amie J Barda, Justin X Moore, Susan Dent, Husam Abdel-Qadir, Aniket A Kawatkar, Ambarish...> ;Journal of the National Comprehensive Cancer Network. 2023 Jul 1
• 1 citations
  Thirty-Day Unplanned Hospital Readmissions in Patients With Cancer and the Impact of Social Determinants of Health: A Machine Learning Approach.
  Nickolas Stabellini, Aziz Nazha, Nikita Agrawal, Merilys Huhn, John Shanahan, Nelson Hamerschlak, Kristin Waite, Jill S Barnholtz-Sloan, Alberto J Montero> ;JCO Clinical Cancer Informatics. 2023 Jul 1
• 2 citations
  Survival in elderly patients with breast cancer with and without autoimmune disease.
  Demitrios Dedousis, Anastasia N Vassiliou, Shufen Cao, Deepthi Yammani, Ravi K Kyasaram, John P Shanahan, Melissa C Keinath, Melinda L Hsu, Pingfu Fu, Afshin Dowlati, ...> ;Cancer Medicine. 2023 Jun 1
• 4 citations
  Allostatic load and cardiovascular outcomes in males with prostate cancer.
  Nickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, Justin X Moore, Lifen Cao, Neal L Weintraub, Ryan A Harris, Xiaoling Wang, Biplab Datta, Steven S Coughlin,...> ;JNCI Cancer Spectrum. 2023 Mar 1
• 10 citations
  Racial disparities in breast cancer treatment patterns and treatment related adverse events.
  Nickolas Stabellini, Jennifer Cullen, Lifen Cao, John Shanahan, Nelson Hamerschlak, Kristin Waite, Jill S Barnholtz-Sloan, Alberto J Montero> ;Scientific Reports. 2023 Jan 22
• Adjuvant Therapy in Breast Cancer Patients With Microscopic Residual Disease.
  Lifen Cao, Robert Shenk, Nickolas Stabellini, Amanda L Amin, Alberto J Montero, Christopher W Towe> ;The Journal of Surgical Research. 2023 May 1
• 1 citations
  Modeling the COVID Pandemic: Do Delays in Surgery Justify Using Stereotactic Radiation to Treat Low-Risk Early Stage Non-Small Cell Lung Cancer?
  Lifen Cao, Philip A Linden, Tithi Biswas, Stephanie G Worrell, Jillian N Sinopoli, Megan E Miller, Robert Shenk, Alberto J Montero, Christopher W Towe> ;The Journal of Surgical Research. 2023 Mar 1
• 8 citations
  Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival.
  Nickolas Stabellini, Benjamin Tomlinson, Jennifer Cullen, John Shanahan, Kristin Waite, Alberto J Montero, Jill S Barnholtz-Sloan, Nelson Hamerschlak> ;Cancer Medicine. 2023 Mar 1
• 1 citations
  Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer.
  Askal Ayalew Ali, Rima Tawk, Hong Xiao, Anastasia Semykina, Alberto J Montero, Richard K Moussa, Olayiwola Popoola, Vakaramoko Diaby> ;Expert Review of Pharmacoeconomics & Outcomes Research. 2022 Jul 1
• 5 citations
  A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis.
  Lifen Cao, Christopher W Towe, Robert Shenk, Nickolas Stabellini, Amanda L Amin, Alberto J Montero> ;Cancer. 2022 Jul 1
• 4 citations
  Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data.
  James M Martin, Elizabeth A Handorf, Alberto J Montero, Lori J Goldstein> ;The Oncologist. 2022 Jun 8
• Reply to "Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer".
  Lifen Cao, Nickolas Stabellini, Amanda L Amin, Alberto J Montero> ;Cancer. 2022 Aug 15
• 144 citations
  Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Nega...
  Francois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, Guillermo Streich, Alberto J Montero, Frédéric Forget, Marie-Ange Mouret-Reynier, Joo Hyuk Sohn, Donatien...> ;Journal of Clinical Oncology. 2022 Oct 1
• 14 citations
  Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community Practice.
  Nickolas Stabellini, Debora S Bruno, Mantas Dmukauskas, Amie J Barda, Lifen Cao, John Shanahan, Kristin Waite, Alberto J Montero, Jill S Barnholtz-Sloan> ;JTO Clinical and Research Reports. 2022 Apr 1
• 2 citations
  Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment.
  Avirup Guha, Nickolas Stabellini, Alberto J Montero> ;Frontiers in Cardiovascular Medicine. 2022 Jan 1
• 3 citations
  Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis
  Lifen Cao, Robert Shenk, Nickolas Stabellini, Megan E. Miller, Christopher W. Towe, Alberto J. Montero> ;Breast Cancer Research and Treatment. 2021 Oct 16
• 1 citations
  CDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER+ Metastatic Breast Cancer
  Priyanka M Reddy, James M Martin, Alberto J. Montero> ;JCO Oncology Practice. 2021 Oct 12
• 10 citations
  Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inh...
  Hanjie Mo, Catherine E Renna, Halle C. F. Moore, Jame Abraham, Megan L. Kruse, Alberto J. Montero, Susan B. LeGrand, Lu Wang, G. Thomas Budd> ;Clinical Breast Cancer. 2021 Oct 9
• ASO Visual Abstract: Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor Positive Breast Cancer Patients-Pathologic and ...
  Lifen Cao, Kavin Sugumar, Eleanor Keller, Pamela Li, Lisa Rock, Ashley Simpson, Alberto J. Montero, Mary Freyvogel, Robert Shenk, Megan E. Miller> ;Annals of Surgical Oncology. 2021 Aug 30
• Join now to see all

Journal Articles

• Re: Xie, J, Diener M, De G et al Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative...  
  Diaby V, Adunlin G, Montero AJ, J Med Econ, 2/10/2014
• Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L  
  Diaz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Salem ML, Wieder E, Komanduri K, Montero AJ , Lichtenheld MG, Immunol Res, 11/12/2013
• Breast Cancer Survival Poorer in Black Women: Commentary  
  Montero AJ, Healio/HemOnc Today, 8/1/2013
• A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer  
  Tan PS, Haaland B, Montero AJ , Lopes G, Breast Cancer Res Treat, 3/31/2013
• Influence of Treatment Modality in Outcomes for Different Stages of Resectable Esophageal Adenocarcinomas  
  Allan BJ, Pedroso F, Gennis ER, Livingstone AS, Montero A , Lally B, Ardalan B, Koniaris LG, Solomon NL, Franceschi D, Ann Surg Oncol, 3/1/2013
• Molecular Profiling for Breast Cancer: A Comprehensive Review  
  Kittaneh M, Montero AJ , Gluck S, Biomarkers in Cancer, 1/1/2013
• Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review  
  Ochoa R, Bejarano PA, Gluck S, Montero AJ, J Med Case Rep, 11/1/2012
• Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple- Negative Metastatic Breast Cancer  
  Montero A , Gluck S, Case Rep Oncol, 9/1/2012
• Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low- dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial  
  Ocean AJ, Pennington KL, Guarino MJ, Sheikh A, Bekaii-Saab T, Serafini AN, Lee D, Sung MW, Gulec SA, Goldsmith SJ, Manzone T, Holt M, O'Neil BH, Hall N, Montero AJ , K..., Cancer, 5/8/2012
• A Phase II Trial of nab- Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer  
  Hosein PJ, de Lima Lopes G Jr, Pastorini VH, Gomez C, Macintyre J, Zayas G, Reis I, Montero AJ , Merchan JR, Rocha Lima CM, Am J Clin Oncol, 2/2/2012
• Myeloid-derived Suppressor Cells in Cancer Patients: A Clinical Perspective  
  Montero AJ , Diaz-Montero CM, Kyriakopoulos CE, Bronte V, Mandruzzato S, J Immunother, 2/1/2012
• Fighting fire with fire: rekindling the bevacizumab debate  
  Montero AJ, Vogel C, N Engl J Med, 1/26/2012
• Search for novel therapies for triple negative breast cancers (TNBC); analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GNRH)  
  Buchholz S, Seitz S, Engel J, Montero A, Ortmann O, Perez R, Block NL, Schally AV, Horm Mol Biol Clin Investig, 1/1/2012
• Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review  
  Montero AJ , Adams B, Diaz-Montero CM, Gluck S, Expert Review of Clinical Pharmacology, 5/1/2011
• Bayraktar UD, Chen E, Bayraktar S, Sands LR, Marchetti F, Montero AJ , Rocha-Lima CM?  
  Bayraktar UD, Chen E, Bayraktar S, Sands LR, Marchetti F, Montero AJ , Rocha-Lima CM, Cancer, 12/17/2010
• Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma  
  Yang R, Cheung MC, Byrne MM, J Xiaoling, Montero AJ , Jones C, Koniaris LG, Archives of Surgery, 1/1/2010
• Cytokines and Angiogenic Factors in Metastatic Renal Cell Cancer: Association of Pretreatment Serum Levels with Survival  
  Montero AJ , Diaz-Montero CM, Liu, J, McIntyre BW, Logothetis C, Tannir N, Ann Oncol, 10/1/2009
• Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination anti-tumor respo...  
  Salem ML, Diaz-Montero C, Alkhami, A, Montero AJ , Cole DJ, J Immunol, 2/15/2009
• Increased Levels of Circulating Myeloid-Derived Suppressor Cells in Solid Tumor Patients Correlate With Advanced Clinical Cancer Stage, Increased Tumor Burden, and Cyc...  
  Marcela Diaz-Montero C, Salem ML, Garrett-Mayer E, Cole DJ, Montero AJ, Cancer Immunol Immunother, 1/1/2009
• Gastrointestinal Stromal Tumors: Review of Molecular Biology and Clinical Implications  
  Jiang Y, Milling DL, Montero AJ, Gastrointestinal Cancer Research, 9/1/2008
• Priming of naive cells in the presence of IL-12 selectively enhances the survival of CD8 +CD62L hi cells and results in superior anti-tumor activity  
  Diaz-Montero CM, El Naggar S, El Naggar R, Al Khami A, Montero AJ , Cole DJ, Salem ML, Cancer Immunol Immunother, 4/1/2008
• Gemcitabine and taxanes in metastatic breast cancer: a systematic review  
  Gudena V, Montero AJ , Gluck S, Therapeutics and Clinical Risk Management, 1/1/2008
•  
  Deng WG, Montero AJ, Wu, KK, Arterioscler Thromb Vasc Biol, 8/1/2007
• Fatal Rhabdomyolysis as a complication of Et-743 (Yondelis) Chemotherapy for Sarcoma: Case Report and Literature Review  
  Skorupa A, Beldner M, Kraft A, Montero AJ, Cancer Biol Ther, 7/1/2007
• Metastatic Chest Wall Malignant Peripheral Nerve Sheath Tumor Responding to Sorafenib: Case Report and Literature Review  
  Gudena V, Verma N, Post G, Kizziah M, Fenning R, Montero AJ, Cancer Biol Ther, 6/1/2007
• Join now to see all